1. Home
  2. Africa
  3. Central African Republic
  • News

French NGO gets land to build HIV/AIDS centre

[Central African Republic (CAR)] Headquarters of the "Comite National de Lutte Contre le VIH/SIDA - CNLS" (National Committee to Fight HIV/AIDS) in Bangui (taken July 2002) IRIN
Siège du Comité National de lutte contre lde VIH/sida (CNLS) à Bangui, Centrafrique (archive de juillet 2002)
Hanuman, a French NGO campaigning against HIV/AIDS has acquired land on which an HIV therapy centre worth US $230,000 will be built. The land was granted by a presidential decree on Tuesday. A leading figure in Hanuman, Bernard Leclerc, who is also an adviser to the president, told IRIN on Wednesday that the centre was expected to begin operating in mid-2003. Local and French physicians and researchers established Hanuman in 2001. At the same time, the NGO is scheduled to sign an agreement with the University of Bangui later in January, to allow Professor Laurent Belec, the chairman of Hanuman, to transform the university's abandoned laboratories into specialised HIV/AIDS laboratories. The cost of rehabilitation and equipment for the project is estimated at US $30,769. The CAR has one of highest rates of infection in central Africa with 14 percent of the population living with the virus, according to Wilibiro Sacko, the coordinator of the CAR's national anti-HIV/AIDS committee. Leclerc also said the NGO would this year sponsor eight specialists for training in France on computer-based HIV treatment and drug prescription. The trainees would include a physician, a pharmacist and a biologist. On their return home, Leclerc said, they would then train other medical specialists. Leclerc told IRIN that Alliance Medica, a French pharmaceutical laboratory, had agreed to provide Bangui with six copies of NADIS computer software, a programme designed specially for HIV treatment. He said the programme would help improve the quality of a patient's medical follow-up. "It enables the user to collect, manage and have access to the data necessary for a medical decision, facilitates clinical studies and research, as well as a global medical assessment," he added.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Get the day’s top headlines in your inbox every morning

Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

It’s the perfect way to start your day.

Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join